The association between obesity, type 2 diabetes mellitus (T2DM), and cardiovascular disease (CVD) is well-established 1. Obesity contributes to the pathogenesis of these conditions through risk ...
The Roux-en-Y Gastric Bypass (RYGB) is one of the most widely used bariatric and metabolic surgeries. It works by reducing the size of the stomach and reconnecting the small intestine to the stomach, ...
BACKGROUND: One anastomosis gastric bypass (OAGB) has gained prominence in the search for better results in bariatric surgery. However, its efficacy and safety compared to Roux-en-Y gastric bypass ...
Completion of recruitment for pivotal Phase 3 LUCIDITY trial of avexitide expected in Q1 2026, with topline data anticipated in Q3 2026 Cash runway expected into 2028, through the potential approval ...
Bariatric surgery was associated with higher short-term risks for acute kidney injury (AKI) and nephrolithiasis but lower long-term risks for chronic kidney disease (CKD) and kidney failure with ...
- Pivotal Phase 3 LUCIDITY trial of avexitide, a potential first-in-class GLP-1 receptor antagonist with FDA Breakthrough Therapy designation, underway in post-bariatric hypoglycemia; completion of ...
Bariatric surgery is a medical procedure that alters the digestive system to help individuals with obesity lose weight by limiting food intake, nutrient absorption, or both. Globally, obesity has ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. If you’re struggling with weight, you’re not alone. Around 42 percent of American adults have obesity. In addition to nutrition, ...
A NEW economic evaluation has shown that bariatric surgery is not only effective in improving survival among patients with obesity and compensated cirrhosis but is also highly cost-effective. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback